Create
Query
event_store.db
—
events
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row 13471 in events
seq
Primary key.
INTEGER
id
evt_de8c994cd48c
TEXT NOT NULL
kind
signal_ingest
TEXT NOT NULL
ts
2026-04-10T03:07:01.502496+00:00
TEXT NOT NULL
actor
daemon:signal_enrichment
TEXT
subject_entity_ids
[]
TEXT
payload
{"created_at":"2026-04-10T03:04:31.796915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:8edb2e8d17a28469","evidence_event_ids":["evt_43efe7e7408d"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","company":"Zeo ScientifiX, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_018928e613e6e69e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:07:01.502448+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt","source_event_id":"evt_43efe7e7408d","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"49d4e09f7483e0f7","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-09","2026-04-10T03:04:31.796915+00:00"],"entities":[{"asset_class":"equity","name":"Zeo ScientifiX, Inc.","relevance":"high","symbol":"ZEOX","type":"issuer"},{"asset_class":"unknown","name":"Regen Therapy","relevance":"high","symbol":"","type":"counterparty"},{"asset_class":"unknown","name":"Stealth Health","relevance":"medium","symbol":"","type":"partner"},{"asset_class":"unknown","name":"Ian T. Bothwell","relevance":"medium","symbol":"","type":"signatory"},{"asset_class":"unknown","name":"Matthew Mazzuca","relevance":"low","symbol":"","type":"quoted_person"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only that this 8-K was filed and what it contains.","The specific terms of the MOU (e.g., duration, exclusivity scope, financial terms, deliverables, regulatory status) are not included in the provided cleaned text beyond high-level positioning.","No explicit guidance or financial impact figures are stated in the provided text.","The filing\u2019s SEC Item number is provided (8.01), but no other material items are listed in the cleaned text beyond Exhibit 99.1."],"key_facts":["SEC filing: Form 8-K filed for Zeo ScientifiX, Inc.","Date of report / earliest event reported: April 9, 2026.","Item 8.01 Other Events: On April 9, 2026, ZEO issued a press release announcing an MOU with Regen Therapy for an exclusive scientific and biologics strategic collaboration.","The MOU is described as positioning ZEO as the core supplier of advanced biologic therapeutics to be incorporated into next-generation regenerative offerings on Regen\u2019s clinical platform.","A copy of the press release is included as Exhibit 99.1.","Exhibit 99.1 press release headline: \u201cRegen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics\u2014Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB: ZEOX)\u201d.","Press release states Regen Therapy has a network of more than 3,000 clinics and 24,000 practitioners across the U.S.","Press release states the collaboration creates a vertically integrated ecosystem combining clinical delivery, telemedicine infrastructure, and biologic product development.","Press release states participating clinics can integrate a licensed prescriber network, pharmacy fulfillment infrastructure, and telemedicine platform into existing operations.","Press release lists services mentioned as available to clinics/patients: physician-guided consultations, compounded medications, hormone replacement therapy, GLP-1 weight management programs, therapeutic peptides, and broader longevity protocols.","Press release includes a quote from Matthew Mazzuca, CEO and Co-Founder of Stealth Health."],"numeric_claims":[{"label":"clinics","value":"3,000"},{"label":"practitioners","value":"24,000"},{"label":"press release date","value":"2026-04-09"}],"primary_claim":"On April 9, 2026, ZEO issued a press release announcing it entered into an MOU with Regen Therapy for an exclusive scientific and biologics strategic collaboration positioning ZEO as the core supplier of advanced biologic therapeutics for Regen\u2019s next-generation regenerative offerings.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Zeo ScientifiX, Inc. (OTCQB: ZEOX) filed a Form 8-K on April 9, 2026 to report it entered into an MOU with Regen Therapy for an exclusive scientific and biologics strategic collaboration. The filing includes Exhibit 99.1, a press release describing ZEO as the core supplier of advanced biologic therapeutics for Regen\u2019s next-generation regenerative offerings.","topics":["SEC filing","Form 8-K","MOU","strategic collaboration","biologics","regenerative medicine","telemedicine","white-label platform","longevity programs","Exhibit 99.1"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Zeo ScientifiX, Inc. \u00b7 Filed 20260409","ticker":"ZEOX","tickers":["ZEOX"],"title":"ZEOX filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-003301.txt"}}
TEXT NOT NULL
source_ref
candidate:sc_018928e613e6e69e
TEXT
confidence
REAL (default 0.0
dedupe_key
signal_enriched:discovery_sec_filing_delta:8edb2e8d17a28469
TEXT
episode_id
NULL
TEXT
created_at
2026-04-10T03:07:01.502555+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel